HER2-, HER3-, and TROP2-Targeted ADCs: Latest Progress, Future Possibilities, and Advancing the Therapeutic Relational Connection

Gain the latest insights on HER2-, HER3-, and TROP2-targeted ADCs, including their characteristics contributing to differing toxicities, recommendations for monitoring and managing associated adverse effects and strategies for overcoming barriers and disparities for patients prescribed these therapies, through on-demand webcasts with accompanying slides and a ClinicalThought commentary.

Share

Program Content

Events

  • Live Event
    HER2-, HER3-, and TROP2-Targeted ADCs: Latest Progress, Future Possibilities, and Advancing the Therapeutic Relational Connectionnal Thoughts and Audience Question and Answer Session
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

HER2 HER3 TROP2 Targeted ADCs
HER2-, HER3-, and TROP2-Targeted ADCs: Latest Progress, Future Possibilities, and Advancing the Therapeutic Relational Connection
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2024

Expires: November 10, 2025

Faculty

cover img faculity

Sara Cooper, MSN, RN, ACNP-BC, AOCNP-BC

Breast Oncology Nurse Practitioner
MemorialCare Cancer Institute
MemorialCare Medical Group
Orange County, California

cover img faculity

Kristi K. Orbaugh, MSN, RNP, AOCNP

Adult Oncology Nurse Practitioner
Community Hospital Oncology Physician
A Partner of MD Anderson
Indianapolis, Indiana

cover img faculity

Kimberly Podsada, MSN, NP-C

Oncology Nurse Practitioner
UCSD Comprehensive Breast Health Center
La Jolla, California

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca and Gilead Sciences, Inc.

AstraZeneca

Gilead Sciences, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner